An observational, prospective study to evaluate the impact of disease burden prior to ide-cel infusion on outcomes in a real-world setting
Latest Information Update: 26 Sep 2024
At a glance
- Drugs Idecabtagene vicleucel (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 26 Sep 2024 New trial record